Structure

InChI Key SNIOPGDIGTZGOP-UHFFFAOYSA-N
Smile O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-]
InChI
InChI=1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2

Physicochemical Descriptors

Property Name Value
Molecular Formula C3H5N3O9
Molecular Weight 227.09
AlogP -1.02
Hydrogen Bond Acceptor 9.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 8.0
Polar Surface Area 157.11
Molecular species NEUTRAL
Aromatic Rings 0.0
Heavy Atoms 15.0

Pharmacology

Action Mechanism of Action Reference
ACTIVATOR Soluble guanylate cyclase activator Wikipedia Wikipedia Wikipedia Wikipedia FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Angina, Stable 4 D060050 ClinicalTrials
Myocardial Infarction 4 D009203 ClinicalTrials
Hypertension 4 D006973 ClinicalTrials
Coronary Disease 4 D003327 ClinicalTrials
Myocardial Ischemia 3 D017202 ClinicalTrials
Stroke 3 D020521 ClinicalTrials
Osteoporosis 3 D010024 ClinicalTrials
Raynaud Disease 3 D011928 ClinicalTrials
Wounds and Injuries 3 D014947 ClinicalTrials
Arthritis, Rheumatoid 3 D001172 ClinicalTrials
Muscle Cramp 3 D009120 ClinicalTrials
Bone Diseases, Metabolic 3 D001851 ClinicalTrials
Reperfusion Injury 3 D015427 ClinicalTrials
Scleroderma, Localized 3 D012594 ClinicalTrials
Hot Flashes 2 D019584 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 2 D002289 ClinicalTrials
Shock 2 D012769 ClinicalTrials
Diabetic Neuropathies 2 D003929 ClinicalTrials
Tendinopathy 2 D052256 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Erectile Dysfunction 2 D007172 ClinicalTrials
Hypertension, Pulmonary 1 D006976 ClinicalTrials
Infections 1 D007239 ClinicalTrials
Rectal Neoplasms 1 D012004 ClinicalTrials
Phlebitis 1 D010689 ClinicalTrials
Inflammation 1 D007249 ClinicalTrials
Hypotension 0 D007022 ClinicalTrials
Peripheral Arterial Disease 0 D058729 ClinicalTrials
Colorectal Neoplasms 0 D015179 ClinicalTrials

Side Effects from Label

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
19.06
Injury, poisoning and procedural complications
11.13
Nervous system disorders
10.6
Cardiac disorders
10.36
Vascular disorders
9.77
Immune system disorders
5.91
Skin and subcutaneous tissue disorders
5.21
Product issues
4.92
Respiratory, thoracic and mediastinal disorders
4.71
Gastrointestinal disorders
4.18
Investigations
2.9
Psychiatric disorders
2.72

Cross References

Resources Reference
CAS NUMBER 55-63-0
ChEBI 28787
ChEMBL CHEMBL730
DrugBank DB00727
DrugCentral 1952
EPA CompTox DTXSID1021407
FDA SRS G59M7S0WS3
Human Metabolome Database HMDB0014865
Guide to Pharmacology 7053
KEGG C07455
PDB TNG
PharmGKB PA450644
PubChem 4510
SureChEMBL SCHEMBL15421
ZINC ZINC000008214625